Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockade

International Journal of Obesity

Volumn 25, Issue 1, 2001, Pages 84-94

  Zuana, O Della ^a   Sadlo, M ^a   Germain, M ^a   Feletou M ^a   Chamorro, S ^a   Tisserand, F ^a   De Montrion, C ^a   Boivin, J F ^a   Duhault, J ^a   Boutin, J A ^a   Levens, N ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Adrenergic receptors; CGP 71683A; Food intake; Muscarinic receptors; Neuropeptide Y; Obesity; Serotonin receptors

Indexed keywords

ADRENERGIC RECEPTOR; CGP 71683 A; MUSCARINIC RECEPTOR; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y5 RECEPTOR; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FOOD INTAKE; HISTOPATHOLOGY; MALE; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; RABBIT; RAT; RECEPTOR BINDING; RECEPTOR BLOCKING;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; ENCEPHALITIS; ENERGY INTAKE; INJECTIONS, INTRAVENTRICULAR; MALE; NAPHTHALENES; NEUROPEPTIDE Y; OBESITY; PYRIMIDINES; RATS; RATS, WISTAR; RATS, ZUCKER; RECEPTORS, MUSCARINIC; RECEPTORS, NEUROPEPTIDE Y; RECEPTORS, SEROTONIN; TIME FACTORS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 17744362652     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801472     Document Type: Article

References (62)

1. The dorsomedial hypothalamic nucleus revisited: 1998 update
2. Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats
3. Physiological regulation of hypothalamic neuropeptide Y release in lean and obese rats
4. Effects of restricted daily feeding on neuropeptide Y release in the rat paraventricular nucleus
5. Intraventricular injection of neuropeptide Y antisera curbs weight gain and feeding, and increases the display of sexual behaviors in obese Zucker female rats
6. ICV administration of anti-NPY antisense oligonucleotide: Effects on feeding behavior, body weight, peptide content and peptide release
7. A potent neuropeptide Y antagonist, 1229U91, suppressed spontaneous food intake in Zucker fatty rats
8. Y-receptor subtypes - How many more?
9. The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes
10. Neuropeptide Y Y1 receptor antisense oligodeoxy-nucleotides enhance food intake in energy-deprived rats
11. Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents
12. NPY-Y1 receptor antisense injected centrally in rats causes hyperthermia and feeding
13. Central administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y
14. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides
15. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor
16. The lack of specificity of neuropeptide Y (NPY) antisense oligodeoxynucleotides administered intracerebroventricularly in inhibiting food intake and NPY gene expression in the rat hypothalamus
17. Emerging functions for neuropeptide Y5 receptors
18. A threonine residue in the seventh transmembrane domain of the human A1 adenosine receptor mediates specific agonist binding
19. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain
20. Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors
21. Rat spinal cord alpha 2-adrenoceptors are of the alpha 2A-subtype: Comparison with alpha 2A- and alpha 2B-adrenoceptors in rat spleen, cerebral cortex and kidney using 3H-RX821002 ligand binding
22. Characterization of quisqualate recognition sites in rat brain tissue using DL-[3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and a filtration assay
23. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart
24. The neutral endopeptidase-24.11 inhibitor SCH 34826 does not change opioid binding but reduces D1 dopamine receptors in rat brain
25. Comparison of [3H]YM-09151-2 with [3H] spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum
26. Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes
27. Heterogeneity of [3H]-mepyramine binding sites in guinea pig cerebellum and lung
28. Reversible and irreversible labeling and autoradiographic localization of the cerebral histamine H2 receptor using [125I]iodinated probes
29. The binding site for [3H]glibenclamide in the rat cerebral cortex does not recognize K-channel agonists or antagonists other than sulphonylureas
30. Characterization of high affinity binding sites for charybdotoxin insynaptic plasma membranes from rat brain. Evidence for a direct association with an inactivating, voltage-dependent, potassium channel
31. Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: Comparison with hippocampal M1, atrial M2 and ileal M3 receptors
32. [3H]cytisine binding to nicotinic cholinergic receptors in brain
33. [3H]CGP 39653: A new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain
34. Opiate receptor binding affected differentially by opiates and opioid peptides
35. Multiple serotonin receptors: Differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol
36. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: Comparison with 5-HT2A and 5-HT2C receptors
37. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding
38. p-Chlorophenylalanine-reversible reduction of sigma binding sites by chronic imipramine treatment in rat brain
39. Characterization of [3H]paroxetine binding in rat brain
40. [3H]N-[1-(2 benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]-BTCP): A new phencyclidine analog selective for the dopamine uptake complex
41. [3H]nisoxetine: A radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding
42. Pharmacological profile of hypericum extract. Effect on serotonin uptake by postsynaptic receptors
43. NPY receptor subtype in the rabbit ileum
44. NPY receptor subtypes involved in the contraction of the proximal colon of the rat
45. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype
46. Characterization of neuropeptide Y-induced feeding in mice: Do Y1-Y6 receptor subtypes mediate feeding?
47. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor
48. Serotonin innervation of neuropeptide Y-containing neurons in the rat arcuate nucleus
49. Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine
50. Stimulation of 5-HT(2A/2C) receptors within specific hypothalamic nuclei differentially antagonizes NPY-induced feeding
51. The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats
52. Modulation of feeding by hypothalamic paraventricular nucleus alpha 1-and alpha 2-adrenergic receptors
53. Yohimbine and rauwolscine reduce food intake of genetically obese (obob) and lean mice
54. Regional distribution of Y-receptor subtype mRNAs in rat brain
55. The effect of hypothalamic peptide YY on hippocampal acetylcholine release in vivo: Implications for limbic function in binge-eating behavior
56. Central nervous system pharmacology of neuropeptide Y
57. Chemokines/intercrines and central regulation of feeding
58. Reduction in food and water intake induced by microinjection of interleukin-1 beta in the ventromedial hypothalamus of the rat
59. Herzog 2-36[K4,RYYSA(19-23)]PP a novel Y5-receptor preferring ligand with strong stimulatory effect on food intake
60. Activation of the NPY Y5 receptor regulates both feeding and energy expenditure
61. 1: L-152, 804: Orally active and selective neuropeptide Y Y5 receptor antagonist
62. Behavioral characterization of neuropeptide Y knockout mice